CXCR4 and head and neck squamous cell carcinoma: One study examined expression of CXCR4 and another chemokine receptor, CCR7, which has been shown to activate the PI3K/Akt pathway in HNSCC, a pathway involved in cell growth, differentiation and survival [100].